Strategic Partnerships
SomnoSense is positioned to benefit from partnerships across both healthcare and research ecosystems.
We aim to collaborate with:
- Sleep clinics and pulmonology practices for clinical validation and pilot testing
- Academic research institutions for data refinement and algorithm development
- Digital health platforms and telemedicine providers for future deployment
These partnerships allow SomnoSense to:
- Validate performance against existing diagnostic standards
- Build clinical credibility prior to large-scale rollout
- Integrate smoothly into existing healthcare workflows
SomnoSense follows a capital-efficient development strategy, minimizing early-stage costs while maximizing proof-of-concept value.
Key cost considerations include:
- Prototype development and materials
- Sensor integration and miniaturization research
- Software and data analysis infrastructure
- Clinical validation and regulatory preparation
Rather than immediate mass manufacturing, early funding is directed toward technical validation, clinical alignment, and intellectual property protection, reducing investor risk.
Revenue Pathways (Future-Oriented)
While SomnoSense is currently in the validation stage, future revenue models include:
- Sale of disposable intraoral patches paired with reusable electronics
- Subscription-based software analytics for clinicians or health platforms
- Licensing of proprietary pH–humidity datasets and AI classifiers for research and industry use
This diversified model allows for flexibility as regulatory and clinical pathways evolve.
To ensure disciplined growth, SomnoSense is structured around a phased roadmap:
Phase 1 — Proof of Concept (Current)
- Arduino-based prototype validation
- Demonstration of humidity-based apnea detection
- Conceptual biochemical sensing validation
Phase 2 — Integration & Miniaturization
- Electronic pH sensor integration
- Miniaturized intraoral patch development
- Expanded data collection
Phase 3 — Clinical Validation
- Pilot studies in controlled environments
- Comparison to polysomnography benchmarks
- Algorithm refinement
Phase 4 — Regulatory & Deployment Preparation
- Regulatory strategy development
- Manufacturing feasibility studies
- Strategic healthcare partnerships
Each phase is designed to build upon prior validation, ensuring that capital investment directly supports measurable progress.
For investors, SomnoSense offers:
- Entry into a large, underdiagnosed medical market
- A product designed for recurring revenue and scalability
- A defensible position built on physiological data integration and intellectual property
- A disciplined, low-risk approach focused on validation before expansion
SomnoSense represents an opportunity to support a medically relevant innovation with clear technical grounding and a realistic path toward impact.